PTC
EVH icon

Petrus Trust Company’s Evolent Health EVH Stock Holding History

Petrus Trust Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,663
Closed -$376K – 611
2024
Q2 		$376K Sell
19,663
-3,679
-16% -$94K 0.04% 345
2024
Q1 		$765K Buy
23,342
+10,065
+76% +$321K 0.07% 78
2023
Q4 		$439K Buy
13,277
+5,909
+80% +$167K 0.04% 277
2023
Q3 		$201K Sell
7,368
-6,444
-47% -$179K 0.02% 529
2023
Q2 		$419K Buy
13,812
+7,400
+115% +$239K 0.05% 228
2023
Q1 		$208K Buy
+6,412
New +$203K 0.03% 468
2022
Q3 		– Sell
-6,903
Closed -$212K – 250
2022
Q2 		$212K Buy
+6,903
New +$201K 0.03% 79

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Petrus Trust Company's EVH Position: Q3 2024 in Review

Petrus Trust Company sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 19,663 shares — an estimated $376K sold.

Petrus Trust Company first reported a position in EVH in Q2 2022 and held it in 7 quarters. The position peaked at $765K in Q1 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Petrus Trust Company reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Petrus Trust Company sold 19,663 Evolent Health shares in Q3 2024, an estimated $376K.
  • Petrus Trust Company first reported a position in Evolent Health in Q2 2022 and held it in 7 quarters.
  • Petrus Trust Company's Evolent Health position peaked at $765K in Q1 2024.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Petrus Trust Company's 13F filing for Q3 2024, filed 14 Nov 2024.